Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Van Steenbergen, Anne ^a   Balteau, Magali ^a   Ginion, Audrey ^a   Ferté, Laura ^a   Battault, Sylvain ^a   Ravenstein, Christophe De Meester De ^a   Balligand, Jean Luc ^a,b   Daskalopoulos, Evangelos Panagiotis ^a   Gilon, Patrick ^a   Despa, Florin ^c   Despa, Sanda ^c   Vanoverschelde, Jean Louis ^a,b   Horman, Sandrine ^a   Koepsell, Hermann ^d   Berry, Gerard ^e   Hue, Louis ^a   Bertrand, Luc ^a   Beauloye, Christophe ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRANSPORTER; CYBB PROTEIN, HUMAN; HEAT SHOCK PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SLC5A1 PROTEIN, HUMAN; SLC5A3 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; GENE KNOCKOUT; GENETICS; HUMAN; HYPERGLYCEMIA; MALE; METABOLISM; MOUSE; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; HEAT-SHOCK PROTEINS; HUMANS; HYPERGLYCEMIA; MALE; MICE; MYOCARDIUM; NADPH OXIDASE 2; RATS; REACTIVE OXYGEN SPECIES; SODIUM-GLUCOSE TRANSPORTER 1; SYMPORTERS;

EID: 85010903512     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41166     Document Type: Article

References (49)

1. Laakso, M. Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study. Circulation 99, 461-462 (1999).
2. King, H., Aubert, R. E., Herman, W. H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431 (1998).
3. Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., Gerstein, H. C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32, 2426-2432 (2001).
4. Kosiborod, M. et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117, 1018-1027 (2008).
5. Squire, I. B. et al. Prognostic value of admission blood glucose concentration and diabetes diagnosis on survival after acute myocardial infarction: results from 4702 index cases in routine practice. Clin Sci (Lond) 118, 527-535 (2010).
6. Dyntar, D. et al. High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation. J Clin Endocrinol Metab 91, 1961-1967 (2006).
7. Nishikawa, T. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790 (2000).
8. Cai, L. et al. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51, 1938-1948 (2002).
9. Fiordaliso, F. et al. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37, 959-968 (2004).
10. Giacco, F., Brownlee, M. Oxidative stress and diabetic complications. Circ Res 107, 1058-1070 (2010).
11. Balteau, M. et al. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovascular research 92, 237-246 (2011).
12. Rosenstock, J. et al. One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target. J Diabetes Complications 27, 492-500 (2013).
13. Wright, E. M., Turk, E. The sodium/glucose cotransport family SLC5. Pflugers Arch 447, 510-518 (2004).
14. Gorboulev, V. et al. Na(+ )-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187-196 (2012).
15. Wright, E. M. Glucose transport families SLC5 and SLC50. Mol Aspects Med 34, 183-196 (2013).
16. Wells, R. G. et al. Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter. Am J Physiol 263, F459-465 (1992).
17. Diez-Sampedro, A. et al. A glucose sensor hiding in a family of transporters. Proc Natl Acad Sci USA 100, 11753-11758 (2003).
18. Pletcher, M. T. et al. Chromosome evolution: the junction of mammalian chromosomes in the formation of mouse chromosome 10. Genome Res 10, 1463-1467 (2000).
19. Barcelona, S., Menegaz, D., Diez-Sampedro, A. Mouse SGLT3a generates proton-activated currents but does not transport sugar. Am J Physiol Cell Physiol 302, C1073-1082 (2012).
20. Aljure, O., Diez-Sampedro, A. Functional characterization of mouse sodium/glucose transporter type 3b. Am J Physiol Cell Physiol 299, C58-65 (2010).
21. Tazawa, S. et al. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1, 5-anhydro-D-glucitol, and fructose. Life Sci 76, 1039-1050 (2005).
22. Grempler, R. et al. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett 586, 248-253 (2012).
23. Lubrich, B., Spleiss, O., Gebicke-Haerter, P. J., van Calker, D. Differential expression, activity and regulation of the sodium/myoinositol cotransporter in astrocyte cultures from different regions of the rat brain. Neuropharmacology 39, 680-690 (2000).
24. Lahjouji, K. et al. Expression and functionality of the Na+/myo-inositol cotransporter SMIT2 in rabbit kidney. Biochim Biophys Acta 1768, 1154-1159 (2007).
25. Haneda, M. et al. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism 39, 40-45 (1990).
26. Zhou, L. et al. Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1). J Cell Biochem 90, 339-346 (2003).
27. Banerjee, S. K., McGaffin, K. R., Pastor-Soler, N. M., Ahmad, F. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 84, 111-118 (2009).
28. Chen, J. et al. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 1, 57-92 (2010).
29. Wright, E. M., Hirayama, B. A., Loo, D. F. Active sugar transport in health and disease. J Intern Med 261, 32-43 (2007).
30. Wright, E. M., Loo, D. D., Hirayama, B. A. Biology of human sodium glucose transporters. Physiol Rev 91, 733-794 (2011).
31. O'Malley, D., Reimann, F., Simpson, A. K., Gribble, F. M. Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 55, 3381-3386 (2006).
32. Diez-Sampedro, A., Lostao, M. P., Wright, E. M., Hirayama, B. A. Glycoside binding and translocation in Na(+ )-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. J Membr Biol 176, 111-117 (2000).
33. Hager, K. et al. Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes. J Membr Biol 143, 103-113 (1995).
34. Balteau, M. et al. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. American journal of physiology. Heart and circulatory physiology 307, H1120-1133 (2014).
35. Zinman, B. et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 373, 2117-2128 (2015).
36. Vrhovac, I. et al. Localizations of Na(+ )-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch 467, 1881-1898 (2015).
37. Song, P., Onishi, A., Koepsell, H., Vallon, V. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. Expert Opin Ther Targets, 1-17 (2016).
38. Lambert, R. et al. Intracellular Na+ Concentration ([Na+[i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport. J Am Heart Assoc 4, e002183 (2015).
39. Wakisaka, M., Nagao, T., Yoshinari, M. Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells. PLoS One 11, e0151585 (2016).
40. Wakisaka, M. et al. Sodium-coupled glucose transporter as a functional glucose sensor of retinal microvascular circulation. Circ Res 88, 1183-1188 (2001).
41. Parker, H. E. et al. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia 55, 2445-2455 (2012).
42. Delaere, F., Akaoka, H., De Vadder, F., Duchampt, A., Mithieux, G. Portal glucose influences the sensory, cortical and reward systems in rats. Eur J Neurosci 38, 3476-3486 (2013).
43. Shen, E. et al. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes 58, 2386-2395, doi: 10.2337/db08-0617 (2009).
44. Taegtmeyer, H., Beauloye, C., Harmancey, R., Hue, L. Insulin resistance protects the heart from fuel overload in dysregulated metabolic states. American journal of physiology. Heart and circulatory physiology 305, H1693-1697 (2013).
45. Berry, G. T. et al. Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J Biol Chem 278, 18297-18302, doi: 10.1074/jbc.M213176200 (2003).
46. Bertrand, L. et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 291, H239-250 (2006).
47. Wang, L., Rolfe, M., Proud, C. G. Ca(2+ )-independent protein kinase C activity is required for alpha1-adrenergic-receptormediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes. Biochem J 373, 603-611 (2003).
48. Bontemps, F., Hue, L., Hers, H. G. Phosphorylation of glucose in isolated rat hepatocytes. Sigmoidal kinetics explained by the activity of glucokinase alone. Biochem J 174, 603-611 (1978).
49. Noppe, G. et al. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKalpha1. J Mol Cell Cardiol 74, 32-43 (2014).